AA
LLY icon

Argent Advisors’s Eli Lilly LLY Stock Holding History

Argent Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.27M Buy
4,391
+34
+0.8% +$34.7K 1.32% 18
2026
Q1 		$4.01M Sell
4,357
-84
-2% -$85.2K 1.09% 23
2025
Q4 		$4.77M Buy
4,441
+187
+4% +$179K 1.33% 17
2025
Q3 		$3.25M Buy
4,254
+15
+0.4% +$11.2K 0.96% 28
2025
Q2 		$3.3M Sell
4,239
-6
-0.1% -$4.66K 1.02% 21
2025
Q1 		$3.51M Buy
4,245
+284
+7% +$236K 1.17% 19
2024
Q4 		$3.06M Sell
3,961
-80
-2% -$66.2K 1.13% 18
2024
Q3 		$3.58M Sell
4,041
-5
-0.1% -$4.5K 1.33% 17
2024
Q2 		$3.66M Sell
4,046
-10
-0.2% -$8K 1.46% 16
2024
Q1 		$3.16M Sell
4,056
-21
-0.5% -$14.9K 1.25% 18
2023
Q4 		$2.38M Sell
4,077
-10
-0.2% -$5.84K 1.04% 20
2023
Q3 		$2.2M Buy
4,087
+51
+1% +$26.3K 1% 22
2023
Q2 		$1.89M Sell
4,036
-75
-2% -$31.5K 0.87% 24
2023
Q1 		$1.41M Sell
4,111
-20
-0.5% -$6.75K 0.67% 39
2022
Q4 		$1.51M Sell
4,131
-400
-9% -$142K 0.78% 34
2022
Q3 		$1.47M Hold
4,531
– – 0.85% 27
2022
Q2 		$1.47M Hold
4,531
– – 0.83% 30
2022
Q1 		$1.3M Hold
4,531
– – 0.7% 47
2021
Q4 		$1.25M Hold
4,531
– – 0.67% 44
2021
Q3 		$1.05M Sell
4,531
-110
-2% -$27.1K 0.6% 52
2021
Q2 		$1.06M Sell
4,641
-195
-4% -$39.2K 0.65% 41
2021
Q1 		$903K Buy
4,836
+1,943
+67% +$380K 0.58% 45
2020
Q4 		$488K Sell
2,893
-1,471
-34% -$220K 0.3% 91
2020
Q3 		$646K Sell
4,364
-60
-1% -$9.29K 0.44% 66
2020
Q2 		$726K Sell
4,424
-147
-3% -$22.6K 0.56% 54
2020
Q1 		$634K Sell
4,571
-30
-0.7% -$4.12K 0.64% 45
2019
Q4 		$648K Buy
+4,601
New +$533K 0.48% 46

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Argent Advisors's LLY Position: Q2 2026 in Review

Argent Advisors increased its Eli Lilly (LLY) stake by 0.78% in Q2 2026, buying an estimated $34.7K and bringing the position to 4,391 shares worth $5.27M. The position accounts for 1.32% of the portfolio, ranked #18.

Argent Advisors first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 4,633 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Argent Advisors held 4,391 shares of Eli Lilly worth $5.27M as of Q2 2026.
  • Argent Advisors bought 34 Eli Lilly shares in Q2 2026, an estimated $34.7K.
  • Eli Lilly made up 1.32% of Argent Advisors's portfolio in Q2 2026, its #18 holding.
  • Argent Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 4,633 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Argent Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.